Search This Blog
Thursday, September 8, 2022
Roche upped to Buy from Neutral by Jefferies
Jefferies's analyst Peter Welford upgrades his rating from Neutral to Buy. The target price has been raised from CHF 355 to CHF 375.
Subscribe to:
Posts (Atom)